WebGeneva, Switzerland – January 10th, 2024 – MPC Therapeutics (MPC Tx), a Swiss biotechnology company focused on metabolism and cellular rejuvenation, today announced the closing of its CHF 1.5 million seed-funding round. Funds will serve to advance MPC Tx’s proprietary small molecule towards clinical trials and open new therapeutic ... Webstayble therapeutics ab publishes supplementary prospectus regarding the rights issue wed, mar 29, 2024 13:25 cet. not for release, publication or distribution, directly or …
CEO, VP R&D - One-carbon therapeutics AB - LinkedIn
WebOne-carbon therapeutics presents at Bio€quity 2024. CEO Ana Slipicevic present the MTHFD2 program and one-carbon therapeutics. Read more » ... Read more » Vinnova grants one-carbon therapeutics money One-carbon therapeutics AB is granted 3,000,000 SEK from Sweden’s innovation agency. Read more » MTHFD2 inhibitors now … WebThe One-carbon team is proud and excited to share our latest paper describing the detailed mode of action of our novel MTHFD1/2 inhibitor under development for… gateway power plant antioch ca
One-carbon Therapeutics AB Info & Löner Bolagsfakta
WebOne-carbon therapeutics presents at Bio€quity 2024. CEO Ana Slipicevic present the MTHFD2 program and one-carbon therapeutics AB in the Hot Topic session at Bio€quity 2024 in Milan. MTHFD2 inhibitors now published in Nature Cancer We are proud that the MTHFD2 inhibitors are now published in the prestigious journal Nature Cancer. WebOne-carbon therapeutics appoints Dr Ana Slipicevic as acting CEO. We are very pleased to announce that Dr Ana Slipicevic has been appointed as acting CEO of one-carbon … WebAhead Therapeutics Biotechnology Research Bellaterra, Cerdanyola del Vallès, Barcelona 498 followers Fighting autoimmune diseases Follow See all 12 employees About us Ahead Therapeutics is a... dawn mitchell facebook